{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:13:06Z","timestamp":1773339186337,"version":"3.50.1"},"reference-count":19,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"the healthcare business of Merck KGaA, Darmstadt, Germany","award":["CrossRef Funder ID: 10.13039\/100009945"],"award-info":[{"award-number":["CrossRef Funder ID: 10.13039\/100009945"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,6,9]]},"DOI":"10.1080\/14796694.2025.2503667","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T01:59:21Z","timestamp":1747619961000},"page":"1779-1786","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy"],"prefix":"10.1080","volume":"21","author":[{"given":"Philipp","family":"Ivanyi","sequence":"first","affiliation":[{"name":"Claudia von Schelling Comprehensive Cancer Center, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-0972","authenticated-orcid":false,"given":"Ash","family":"Bullement","sequence":"additional","affiliation":[{"name":"Delta Hat, Ltd","place":["Nottingham, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Botticelli","sequence":"additional","affiliation":[{"name":"Sapienza Universit\u00e0 di Roma","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Perri","sequence":"additional","affiliation":[{"name":"IRCCS Pascale","place":["Naples, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio L.","family":"Colombo","sequence":"additional","affiliation":[{"name":"University of Pavi","place":["Pavia, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1972-9075","authenticated-orcid":false,"given":"Viviana","family":"Annibali","sequence":"additional","affiliation":[{"name":"Merck S.p.A","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Gandola","sequence":"additional","affiliation":[{"name":"An Affiliate of Merck Healthcare KGaA, Global Market Access & Pricing Oncology (GVAP)","place":["Darmstadt, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-350X","authenticated-orcid":false,"given":"Jaesh","family":"Naik","sequence":"additional","affiliation":[{"name":"Delta Hat, Ltd","place":["Nottingham, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schlichting","sequence":"additional","affiliation":[{"name":"Merck KGaA, Advanced Biostatistical Sciences","place":["Darmstadt, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7763-9326","authenticated-orcid":false,"given":"Chris P.","family":"Pescott","sequence":"additional","affiliation":[{"name":"Merck Healthcare KGaA, Global Value Demonstration Oncology (GVAP)","place":["Darmstadt, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,5,18]]},"reference":[{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00224-3"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci11020042"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102371"},{"key":"e_1_3_9_6_1","unstructured":"European Medicines Agency (EMA). Erbitux (cetuximab) - summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/erbitux-epar-product-information_en.pdf"},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802656"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv268"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.6002"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02198"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00332"},{"key":"e_1_3_9_13_1","unstructured":"Latimer N. NICE DSU TSD 14: survival analysis for economic evaluations alongside clinical trials \u2013 extrapolation with patient-level data. National Institute for Health and Care Excellence; 2011. Available from: http:\/\/nicedsuNa.org.uk\/wp-content\/uploads\/2016\/03\/NICE-DSU-TSD-Survival-analysis.updated-March-2013.v2.pdf"},{"key":"e_1_3_9_14_1","unstructured":"Woods B Sideris E Palmer S et al. NICE DSU TSD 19. Partitioned survival analysis for decision modelling in health care: a critical review. National Institute for Health and Care Excellence; 2017. https:\/\/www.sheffield.ac.uk\/nice-dsu\/tsds\/partitioned-survival-analysis"},{"key":"e_1_3_9_15_1","unstructured":"Agenzia Italiana del Farmaco (AIFA). Linee guida: per la compilazione del dossier a supporto della domanda di rimborsabilit\u00c0 e prezzo di un medicinale ai sensi del D.M. 2 agosto 2019. 2020. Available from: https:\/\/www.aifa.gov.it\/documents\/20142\/1307543\/2021.01.22_estratto_linee_guida_sezione_E.pdf"},{"key":"e_1_3_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01215-w"},{"key":"e_1_3_9_17_1","unstructured":"National Institute for Health and Care Excellence (NICE). TA661: pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma | guidance | NICE. 2020. Available from: https:\/\/www.nice.org.uk\/guidance\/ta661"},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-022-00772-7"},{"key":"e_1_3_9_19_1","unstructured":"Salute MD. Health Ministry 2013 National Tariff Nomenclator. Nomenclatore delle Prestazioni di assistenza specialistica ambulatoriale. 2013. Available from: https:\/\/www.salute.gov.it\/portale\/home.html"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.09.625"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.466"}],"updated-by":[{"DOI":"10.1080\/14796694.2025.2541136","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000}}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2503667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:09:25Z","timestamp":1773302965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2503667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":19,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,6,9]]}},"alternative-id":["10.1080\/14796694.2025.2503667"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2503667","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}